Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2018 Oct 15.
Published in final edited form as: Cancer Prev Res (Phila). 2017 Jun 2;10(8):442–450. doi: 10.1158/1940-6207.CAPR-17-0010

Pigs, unlike mice, have two distinct colonic stem cell populations similar to humans that respond to high-calorie diet prior to insulin resistance

Venkata Charepalli 1,^, Lavanya Reddivari 2,^, Sridhar Radhakrishnan 1,$, Elisabeth Eriksson 3, Xia Xiao 4, Sung Woo Kim 5, Frank Shen 6, Vijay-Kumar Matam 4,7, Qunhua Li 6, Vadiraja B Bhat 8, Rob Knight 9,10, Jairam K P Vanamala 1,11,12,*
PMCID: PMC6188705  NIHMSID: NIHMS882829  PMID: 28576788

Abstract

Basal colonic crypt stem cells are long lived and play a role in colon homeostasis. Previous evidence has shown that high-calorie diet (HCD) enhances colonic stem cell numbers and expansion of the proliferative zone, an important biomarker for colon cancer. However, it is not clear how HCD drives dysregulation of colon stem cell/colonocyte proliferative kinetics. We used a human-relevant pig model and developed an immunofluorescence technique to detect and quantify colonic stem cells. Pigs (n = 8/group) were provided either standard diet (SD; 5 % fat) or HCD (25 % fat) for 13 weeks. HCD and SD consuming pigs had similar total calorie intake, serum iron, insulin, and glucose levels. However, HCD elevated both colonic proliferative zone (KI-67) and stem cell zone (ASCL-2 and BMI-1). Proliferative zone correlated with elevated innate colonic inflammatory markers TLR-4, NF-kB, IL-6 and lipocalin-2 (r ≥ 0.62, p = 0.02). Elevated gut bacterial phyla proteobacteria and firmicutes in HCD consuming pigs correlated with proliferative (r ≥ 0.67, p = 0.05) and stem cell zone (r ≥ 0.66, p = 0.05). Colonic proteome data revealed the upregulation of proteins involved in cell migration and proliferation, and correlated with proliferative and stem cell zone expansion. Our study suggests that pig colon, unlike mice, has two distinct stem cells (ASCL-2 and BMI-1) similar to humans and HCD increases expansion of colonic proliferative and stem cell zone. Thus, pig model can aid in development of preventive strategies against gut bacterial dysbiosis and inflammation promoted diseases such as colon cancer.

Keywords: Colon stem cells, inflammation, high-calorie diet, glucose tolerance, gut bacteria

Introduction

The colon is responsible for absorption of water, minerals, and maintaining an immune tolerant symbiotic relationship with the commensal bacteria. As a result, the epithelial cell lining of the colon is under constant exposure to the luminal contents resulting in a remarkably high rate of cell death, with up to 1011 epithelial cells (~200 g) being lost every day in humans (1). This high rate of cell death requires continuous and rapid replacement of the cells, which is driven by small populations of long-lived adult stem cells that reside in specialized niches. These stem cells reside in the bottom of the crypt away from the luminal contents. Recent evidence suggest that dysregulation of colon stem cell kinetics not only leads to gut permeability but also colon cancer (2).

Chronic inflammation generates reactive chemical entities (e.g., reactive oxygen, nitrogen, and halogen species) to neutralize invading pathogens, which may also impose chemical damage on nucleic acids and proteins in surrounding cells (3,4). Prolonged chronic inflammation over a long period, such as in a HCD scenario, may result in chemical damage that exceeds the repair capabilities of the exposed cells, leading to cell death or genetic and epigenetic modifications and the possibility of oncogenic transformation (4). In this context, it is noteworthy that these colonic stem cells (SCs) play an essential role in maintaining tissue homeostasis and wound repair in the colon by their capacity to self-renew and differentiate to replace the injured cells that die from inflammation and/or injury (5). The same properties also make stem cells prime candidates for accumulating mutations that can result in their transformation to oncogenic stem cells.

Emerging evidence suggests that HCD has a causal link to colon cancer and type 2 diabetes (6,7). Prolonged consumption of HCD results in alterations of gut microbiome (8), low-grade colonic, and systemic inflammation/oxidative stress (9,10). These factors may contribute to enhanced intestinal permeability, insulin resistance, glucose intolerance (11), and hypoferremia ultimately leading to elevated risk for colon cancer and type 2 diabetes. Dysregulation of intestinal stem cell kinetics plays a critical role in colon carcinogenesis, however it is not clear which of these factors drive the dysregulation, leading to elevated proliferative zone, a well-established risk factor for colon cancer.

There are a wide variety of markers available for the identification of colonic stem cells in murine models such as ASCL-2 (12), BMI-1 (13), and LGR5 (14). ASCL-2 has been shown to identify stem cells associated with homeostatic regeneration, while BMI-1 marks quiescent stem cells that proliferate only during extreme stress/injury to the colonic epithelium (15). In this study, we optimized ASCL-2 and BMI-1 stem cell markers and KI-67 proliferation marker for use on pig colonic tissue to evaluate the colonic stem cell and epithelial cell kinetics using immunofluorescence.

To better understand molecular mechanisms of HCD altered colonic epithelial kinetics we utilized functional proteomic studies. Alterations at the protein level can reflect cellular changes more accurately. Advances in bioinformatics and high-throughput technologies have provided powerful tools for unraveling the proteomic profile to identify mechanisms of action of dietary components. As there is no information available on human-relevant pig colon mucosal proteomics, we developed a high-throughput non-targeted, ion-thermal focusing electrospray AJS-ESI LC-MS/MS (Jet Stream Proteomics) approach to identify colon mucosal proteins directly. Additionally, the aim of this study was to use proteomics to identify the protein pathways that associate with the changes in the proliferative and stem cell zone in the pig colon.

Materials and methods

Diet-induced inflammation

For the study (Figure 1A) male pigs (6 weeks old, breed: SPG) were obtained from Murphy-Brown LLC (Warsaw, NC), and housed individually in solid indoor pens at the North Carolina State University Swine Educational Unit (Clayton, NC). The animals were divided into different treatment groups by body weight, so that mean initial body weight was similar between the treatment groups (N = 8 animals/treatment). Given the number of animals per treatment or sample size being n = 8, we only used male pigs as the hormonal changes involved with female pigs would add additional variables that can confound the parameters measured in the current exploratory study. Feed intake was measured weekly until the end of the study. The dietary composition of standard diet and high-calorie diet (HCD) are mentioned in table 1. Poultry fat consists of 32 % saturated and 68 % unsaturated fat while the dry fat used in HCD consists of 41 % saturated and 60 % unsaturated fat. The vitamin levels in vitamin mix are listed in supplementary table 2. The plant based sources – corn and soybean meal were all obtained from the same source and batch.

Figure 1.

Figure 1

(A) Study design - After weaning, pigs were divided into two groups and fed high-calorie diet or standard diet for 13 weeks. High-calorie diet consuming pigs had similar calorie intake (B), fasting serum levels of insulin (C), glucose (D) and iron (E) compared to standard diet consuming pigs. Insulin was measured using a radioimmunoassay following the manufacturer's protocol (Millipore). Glucose was measured using a commercially available kit (Cayman). Serum iron levels were measured as described in methods. Results are expressed as mean ± SE for 7–8 animals in each treatment group. SD, standard diet; HCD, high-calorie diet.

Table 1.

Composition of diets used in the study

Ingredients (% of diet weight) Standard Diet High-Calorie Diet
C1 C2
Corn 75.75 56.39
Soybean meal w/o hulls 21 21
L-Threonine 0 0.05
L-Lysine HCl 0.15 0.2
DL-Methionine 0 0.06
Total minerals 0.15 0.15
Salt 0.32 0.32
Vitamin mix 0.03 0.03
Poultry fat 1 3
Dry fat 0 17.1
Dicalcium Phosphate 0.9 1
Limestone 0.7 0.7
Total 100 100

Dry matter 89.6 91.7
Metabolizable energy (Mcal/Kg) 3388 4278
Crude protein 16.4 14.9
Lysine 0.84 0.84
Methionine 0.5 0.5
Tryptophan 0.16 0.15
Threonine 0.52 0.52
Fat 4.7 23
Calcium 0.6 0.62
Phosphorus available 0.23 0.24
Phosphorus total 0.52 0.48

Serum Insulin and glucose levels

Insulin was measured using a radioimmunoassay following the manufacturer’s protocol (Millipore, Billerica, MA). Glucose was measured using a commercially available kit (Cayman, Ann Arbor, MI) following standard recommended protocol. Both insulin and glucose were measured after a 12 hour fast at week 11 of the study.

Serum total iron levels

Serum total iron was measured according to the procedure described previously using a kit from Ricca Chemical Company, Arlington, TX) (16). In brief, non-hemolyzed serum samples were mixed with an equal volume of acid solution to precipitate protein and liberate protein-bound iron. After centrifugation at 6,200 g for 10 min, clear supernatants were collected and mixed with an equal volume of chromogen solution (1.5 M ferrozine and 1.5 M saturated sodium acetate). After 10 min incubation at room temperature, the absorbance was measured at 562 nm.

Colon tissue collection

The animals were euthanized at the end of the study using a captive bolt method. The distal colon was resected, and the mucosa was collected and stored at −80 °C until further analysis. Separately, a part of the distal colon was cleaned with RNAse-free phosphate-buffered saline, cut into pieces of 1 cm and fixed with 10 % buffered formalin. Paraffin-embedded tissues were sectioned at 4 µm and mounted on silane-coated slides for further analysis.

Hematoxylin and eosin staining

Deparaffinized slides were dipped in Harris hematoxylin (Fisher Scientific, Waltham, MA) for 1 minute and washed in water/acid alcohol (0.03 % HCL in 70 % ethanol). The slides were then dipped in Eosin for 1–2 minutes and gradually dehydrated in increasing concentrations of ethanol (100-100-95-70 v/v). Mounting media (Poly Sciences Inc., Warrington, PA) was applied before placing cover slips.

Immunofluorescence staining

Pre-treatment of slides

Prior to staining, the paraffin was softened and the tissue specimens fixed additionally by baking the slides in an oven at 55°C for 20 minutes. Deparaffinization was performed with a clearing agent (Citrisolv, Fisherbrand, Pittsburgh, PA) twice for 5 minutes and hydrated with decreasing concentrations of ethanol (100-100-95-70 v/v). For target retrieval, the slides were incubated in citrate buffer at pH 6 (1 mM citric acid) at 95°C for 20 minutes. To quench autofluorescence from formalin residues, slides were pretreated with sodium borohydride (1 mg/ml) for 5 minutes. Pig sections were blocked with mouse IgG serum from the M.O.M kit (Vector Labs, Burlingame, CA) and avidin/biotin as per the manufacturer’s instructions (Vector Labs). The sections were blocked with superblock (Fisher Scientific, NH) and avidin/biotin.

KI-67

KI-67 antibody staining was performed using a mouse anti-KI-67 (Novocastra, Chicago, IL) for 1 hour at 37°C. Biotinylated horse anti-rabbit secondary antibody (Vector Labs, Burlingame, CA) with streptavidin rhodamine was used. Mounting media with DAPI (Vector Labs, Burlingame, CA) was used as a counterstain.

ASCL-2 and BMI-1

ASCL-2 staining was performed at 4°C overnight using a rabbit anti-ASCL-2 antibody (Abcam, Cambridge, MA). BMI-1 antibody staining was performed using a goat anti-BMI-1 (LSBio, Seattle, WA) at 4°C overnight. Biotinylated goat anti-rabbit secondary antibody and biotinylated horse anti-goat secondary antibody with streptavidin fluorescein were used for ASCL-2 and BMI-1, respectively. The antibodies for ASCL-2 and BMI-1 were epitope matched with the pig protein sequences from the NCBI database. Additionally, negative controls were used to ensure there is no false positive staining. Additional sample images of the staining can be seen in the supplementary information (Supplementary Figure 1). Since the antibodies used were originally developed for human tissue, we stained normal human colon tissue sections and observed similar staining patterns (Supplementary Figure 2). Mounting media with DAPI (Vector Labs, Burlingame, CA) was used as a counterstain. All images were taken using Olympus BX-63 microscope with cellSens software.

Proliferative zone and index analysis

Only U-shaped longitudinally cut crypts with open lamina and base touching the muscularis mucosa were selected for assessing the yield and distribution of labelled cells along the crypt. 20–25 crypts per animal were counted. The total number of immunoreactive nuclei as well as the total number of nuclei per crypt column was counted. The proliferation index was defined as the percentage labeled cells of the total number of crypt column cells. To assess the distribution of the labeled cells, the proliferative zone was calculated as the number of cells from the base to the most upper labelled cell divided by the total number of cells in the column multiplied by 100.

Stem cell zone analysis

Three non-serial sections per animal were used for stem cell zone analysis. ASCL-2 and BMI-1 were used as the marker for stem cells. We obtained epitope-matched antibodies for ASCL-2 and BMI-1and developed a protocol for reliably staining the stem cells in the pig colon. Only U-shaped, longitudinally cut crypts with open lamina and base touching the muscularis mucosa were selected for assessing the yield and distribution of labeled cells along the crypt. The total number of immunoreactive nuclei and the total number of nuclei per crypt column were counted. To assess the distribution of the labeled cells, the stem cell zone was calculated (n = 8 crypts/animal) as the position of the cell from the base to the most upper-labeled cell divided by the total number of cells in the column multiplied by 100 (Supplementary Figure 3). At least 50 crypts positive for stem cell(s) were counted per treatment (on an average, 5 crypts stained positive out of 15–20 “U” shaped crypts per section).

Statistical analysis

Completely randomized block design was used in this study. Individual pigs were the experimental unit. The statistical procedure - mixed procedure PROC MIXED in SAS software (SAS Institute, Cary, NC) was used for analysis of the serum markers, stem cell zone and proliferative index and zone. The results were expressed as means ± S.E. for each treatment.

Gut bacterial sequencing

Genomic DNA was extracted using Powersoil DNA extraction kit (Mo Bio, Carlsbad, CA) from pig distal digesta samples. The hyper-variable region 4 of the 16S ribosomal RNA gene was then amplified and sequenced on an Illumina HiSeq platform, yielding 83,757,806 sequences across 1,151 samples (17). Operational taxonomic units (OTUs) were picked with multiplexed and quality filtered reads using UCLUST OTU picking algorithm (18) against the 13_5 release of Greengenes (19) using updated 13_8 taxonomy strings. The reads that failed to match the reference database at 97% identity was discarded in order to increase the statistical power of downstream analysis, the OTU table was initially filtered to only include OTUs that were present in at least 20 samples with a minimum count of 100 sequences, then rarefied at 22,000 sequences per sample. The OTU (operational taxonomic units) reads of each bacteria for each animal were correlated to the proliferative index and zone as well as stem cell zone (ASCL-2 and BMI-1) data of each animal using spearman correlation.

Proteomics

Distal colon mucosal protein was extracted using complete mammalian proteome extraction kit (Millipore, Billerica, MA). After protein extraction, 100 µg each of protein samples were reduced, alkylated, and double-trypsin digested. Dried peptides were reconstituted in 0.1% formic acid and 20µg of tryptic peptides were injected onto a Polaris 2 mm × 100 mm C18 RP column using UHPLC at 0.4mL/min flow rate. All the samples were analyzed in triplicates on a high flow LC/AJS-dual ion Funnel Q-TOF mass spectrometer using a 30-minute gradient. The LC-MS/MS data was searched against NCBInr Sus scrofa (pig) database using Spectrum Mill bioinformatics tool and results were summarized at 1% FDR. Since there is no protein pathway database for pig proteins, we converted the pig proteins to human equivalent proteins using NCBI genbank accession IDs. Additionally, since the pigs were used as a model for human physiology, only proteins with human homologs were considered in the study.

Proteomics correlations

The main analysis consisted of three steps: an exploratory analysis of the protein profile, identification of the proteins that are correlated with the treatment groups, and a correlation analysis between the selected pathways and the stem cell/colon epithelial cell kinetics.

First, the data was cleaned to remove inconsistencies. Proteins that were not detected in multiple technical replicates were removed from the data as spurious signatures. The exploratory analysis was performed on the cleaned data using multidimensional scaling and Ward’s hierarchical clustering. These unsupervised clustering methods showed that there were clear patterns in the data that corresponded to the dietary treatment groups (Supplementary Figure 4). Since the treatment correlated with the protein profile, the next stage of the analysis involved looking for the proteins responsible for the correlation between the observed protein data and the treatment groups.

Sparse Partial Least Squares Discriminant Analysis (sPLS-DA) was used to identify the proteins responsible for the correlation between the overall protein data and the treatment groups. sPLS-DA is a regression-based method for supervised clustering that can also provide sparse feature selection. Since our goal is to find a small subset of proteins that are related to the treatment groups, sPLS-DA is suitable for this analysis. As sPLS-DA uses a variable sparsity penalty, ten-fold cross validation was used to determine the sparsity penalty. The resulting list of proteins related to the treatment groups was further analyzed using Ingenuity Pathway Analysis to identify the chemical pathways that may be related to the treatment groups. Fisher's exact test was used to calculate the p-value, determining the probability that each canonical pathway assigned to this data set was not due to chance alone.

For correlation analysis between the selected pathways and the stem cell/colon epithelial cell kinetics, a linear regression was performed to evaluate the association between the proteins in the identified pathways and the stem cell/colon epithelial cell kinetics. The adjusted R2 values were calculated for each pathway. The significance of the adjusted R2 values was confirmed using bootstrapping. The adjusted R2 values for the IPA pathways were compared to the adjusted R2 values for 10,000 randomly generated pathways. Only IPA pathways that had an adjusted R2 greater than 95 % of the randomly generated pathways were considered significant.

Results

Pigs consuming high-calorie diet had no change in serum iron, insulin, and glucose

SD consuming pigs had a higher feed intake than HCD consuming pigs. This is likely because SD was a less energy dense diet (Table 1), though the calorie intake was similar between the groups (Fig. 1B). Animals were fasted for 12 hours and serum was collected to measure serum insulin/glucose. We did not observe any differences in serum iron, insulin or glucose between SD and HCD consuming pigs (Figure 1C–E). The body weight gain and feed intake over the period of the study were also similar between the treatment groups (Supplementary Table 1). The lack of significant differences between the SD- and HCD-fed pigs for above mentioned parameters allowed us to compare the effect of diet on colonic epithelial cells and bacteria independent of calorie intake, serum iron, insulin, and glucose levels.

High-calorie diet elevated proliferative zone and index of colonic epithelial cells

HCD has been shown to increase the risk for colon cancer (20). A recent study showed the causal link between HCD and colon cancer (21). Proliferative zone and index in the crypt are elevated in colon cancer (22,23) we measured both the proliferative zone and index in SD and HCD consuming pigs. HCD elevated proliferative zone significantly (Figure 2A). There was a trend towards elevated proliferative index in HCD consuming pigs compared to SD (Figure 2B).

Figure 2.

Figure 2

High-calorie diet elevated proliferative zone (A) and proliferative index (B) in the pig colon crypt. Quantification was performed by immunofluorescence using proliferative marker KI-67. Results are expressed as mean ± S.E. for 7–8 animals in each treatment group. Means that differ by a common letter (a, b) differ (P < 0.05). At least 25 crypts per animal were analyzed. SD, standard diet; HCD, high-calorie diet.

High-calorie diet elevated stem cell zone

Colonic stem cells have been shown to be marked by various markers such as LGR5/ASCL-2 (12) and BMI-1 (13). Additionally, it was shown that ASCL-2 and BMI-1 stain different subsets of stem cells that are involved in extreme stress response (15). Hence, we used epitope-matched antibodies against ASCL-2 and BMI-1 to detect colonic stem cells in the colon crypts of the pigs (Figure 3). The stem cell zone was calculated separately for ASCL-2 and BMI-1. The stem cell zone detected using ASCL-2 was significantly elevated (23 %) in HCD consuming pigs compared to SD (Figure 3A and 3C). BMI-1 stem cell zone was also elevated in HCD consuming pigs but was not significant (Figure 3B and 3D).

Figure 3.

Figure 3

High-calorie diet elevated stem cell zone in the pig colon crypt. Quantification was performed by immunofluorescence using ASCL-2 (A) and BMI-1 (B) stem cell marker for stem cell zone. Results are expressed as mean ± S.E. for 7–8 animals in each treatment group. Means that differ by a common letter (a, b) differ (P < 0.05). At least eight crypts per animal were analyzed. SD, standard diet; HCD, high-calorie diet. (C) and (D) Stem cell marker ASCL-2 and BMI-1 were used to identify colonic stem cells respectively. ASCL-2 and BMI-1 were detected at the base of the crypt and circled. DAPI (blue) was used as a nuclear counter stain. Images are at 20×. Scale bars represent 50 µm.

Proliferative zone and index highly correlated with innate inflammatory markers

We correlated the proliferative zone and proliferative index with inflammatory markers measured in the colonic mucosa (Supplementary table 3) to understand the functional relevance of this elevation in proliferation to inflammation. Proliferative zone significantly correlated with inflammatory markers TLR-4, NF-κB and IL-6 (Table 2). Proliferative index significantly correlated with IL-6. Additionally, lipocalin-2, a fecal inflammatory marker was significantly elevated in the distal colon digesta of HCD-fed pigs and was significantly correlated with proliferative zone.

Table 2.

HCD elevated proliferative zone and index highly correlated with elevated colonic inflammatory markers.

Proliferative
Zone
Proliferative
Index
TLR-4 NF-κB IL-6 Lipocalin-2
Proliferative Zone N/A 0.709** 0.600* 0.569* 0.743** 0.626**
Proliferative Index 0.709** N/A 0.121 0.099 0.604* 0.319
*

is significant at the 0.05 level.

**

is significant at the 0.01 level.

HCD induced alterations in bacteria correlated with proliferative and stem cell zone

HCD resulted in an altered abundance of the bacteroidetes and firmicutes phyla in vivo (24,25). Studies in pigs have shown that lean cloned pigs contained relatively more bacteria belonging to the phylum firmicutes and less from the phylum bacteroidetes than obese cloned pigs. Proliferative index positively correlated with proteobacteria while negatively correlated with firmicutes and bacteroidetes (Figure 4). Proliferative zone positively correlated with firmicutes. Stem cell zone (ASCL-2) also positively correlated with proteobacteria and negatively correlated with firmicutes, which was increased in HCD scenario (Figure 4). BMI-1 stem cell zone significantly correlated with bacterial changes compared to the other markers. BMI-1 stem cell zone positively correlated with proteobacteria and negatively correlated with a majority of firmicutes. Overall from the data, it is evident that stem cell zone (ASCL-2 and BMI-1) and proliferative index positively correlated with proteobacteria, which has been shown to be consistently elevated in high-fat diet/obesogenic conditions and inflammatory bowel diseases.

Figure 4.

Figure 4

Correlation heat map between colonic phyla level bacteria to colonic epithelial cell kinetics. Significant correlations (p < 0.05) are shown with “+” sign. The scale bar on the right shows correlation value from “1 to −1”. The bacteria are shown at phyla and family level.

Proteomics data and exploratory analysis reveals high correlation with pathways associated with colon cancer

Our analysis of distal colon mucosa using Jet Stream Proteomics revealed around 6,000 unique proteins with about 4,000 being consistently detected over multiple runs (proteins that were not present in all the three replicates of at least one sample were considered to be artifacts and discarded for analysis). The accession numbers of the proteins that were significantly different were uploaded to IPA (Ingenuity Pathway Analysis) database to obtain the list of pathways. However, the list of pathways produced by IPA is based on the number of proteins present in the pathway. As proteins are either decreased/increased based on their function or stimuli, the pathway list generated by IPA cannot be used to draw associations. Hence, we correlated the proteins in each of these pathways to our colonic epithelial cell kinetics parameters and generated rankings based on the strength of the correlations (described in methods). This resulted in generating the top pathways with proteins that correlate with elevated colonic epithelial cell kinetics (Table 3). The top pathways that correlate with stem cell zone (ASCL-2 and BMI-1) are primarily involved in the migration/motility (Rho-GDI, Gap junction, FLT3) and proliferation (FAK, ERK/MAPK, eIF4). Additionally, mTOR signaling pathway which has been shown to alter stem cell proliferation in response to calorie changes (26) also correlated with stem cell zone. Similarly, proliferative zone and index correlated with pathways that are involved in cancer progression (Tissue factor, Breast cancer regulation by Stathmin1), migration/motility (Actin cytoskeleton, FL3), and proliferation (Rac, Neuregulin and Cdc42) along with glucocorticoid receptor signaling that is involved in T cell activation (27).

Table 3.

List of top altered pathways for stem cell zone, proliferative zone, and proliferative index

Stem cell zone Proliferative zone and index
Rho-GDI Signaling Role of Tissue Factor in Cancer
FLT3 Signaling in Hematopoietic Progenitor Cells Breast Cancer Regulation by Stathmin1
Breast Cancer Regulation by Stathmin1 Gap Junction Signaling
ERK/MAPK Signaling Glucocorticoid Receptor Signaling
mTOR Signaling Actin Cytoskeleton Signaling
FAK Signaling Rac Signaling
Regulation of eIF4 and p70S6K Signaling FLT3 Signaling in Hematopoietic Progenitor Cells
Gap Junction Signaling Neuregulin Signaling
Semaphorin Signaling in Neurons Regulation of IL-2 Expression in Activated and Anergic T Lymphocytes
STAT3 Pathway Cdc42 Signaling

Discussion

In the present study, we demonstrate that HCD drives the expansion of colonic stem cell zone and proliferative zone before the onset of dysregulated glucose metabolism and weight gain in a human-relevant pig model. The expansion of the colonic stem cell zone and proliferative zone may be due to the altered gut bacterial signature and elevated inflammation, which is supported by strong correlations.

Previous evidence has shown that proliferative cell numbers in the crypt are elevated in colon cancer (28). Further, recent evidence has shown that HCD elevated intestinal stem cell numbers and their proliferative function ex vivo (2). As HCD has a causal link to colon cancer (20), we measured both the stem cell zone and proliferative zone in SD and HCD consuming pigs. SD consuming pigs had higher food intake, but the overall calorie intake was similar between the two groups. HCD consumption in pigs had similar levels of serum iron, insulin and glucose compared to SD (Figure 1B–E). This allowed us to look at the impact of HCD intake in the absence of metabolic dysfunction such as glucose intolerance, hypoferremia and weight gain. This is particularly significant because recent research has shown that HCD first affects the intestine in the form of altered gut bacterial changes and permeability, which can eventually lead to glucose intolerance (29).

HCD significantly elevated both ASCL-2 stem cell zone and proliferative zone (Figure 2 and 3). We have developed a simple and specific immunofluorescence assay for the detection of stem cells in the pig colon crypts, and thus were able to assess the effect of HCD on colonic stem cells in a human-relevant animal model. The assay employs epitope matched antibodies and optimized incubation times for antibody staining to specifically detect stem cells using two different markers - ASCL-2 and BMI-1 (Figure 3). ASCL-2 positive stem cells have been shown to participate in regular homeostasis and its increase was corresponding to the increase in the proliferative zone. BMI-1 stem cell zone increase was not significant, this can be attributed to the fact that earlier studies have shown that BMI-1 positive stem cells are quiescent and activated in extreme stress such as radiation exposure in mice (15). Unlike mice, pig gastrointestinal tract is anatomically and physiologically more similar to humans than any other non-primate mammals. For example, BMI-1 stem cell population is not present in mouse colon (30) but here we show that pig does contain BMI-1 population of stem cells similar to that of human colon (31). The increase in stem cell zone and the proliferative zone was independent of calorie intake, and before the onset of glucose intolerance, thus indicating that HCD consumption alone can cause an increase in stem cell zone and proliferative zone.

HCD-induced alterations in colonic bacteria and activation of toll-like receptor (TLR) are key elements in the induction of the innate inflammatory response via triggering signaling cascades including the transcription factor NF-κB (9,32). Further, high amounts of saturated fatty acids present in high-fat diets can directly activate TLR/NF-κB mediated pro-inflammatory signaling pathways (33,34). HCD consuming pigs had elevated levels of inflammatory markers TLR-4 and NF-κB (Supplementary table 3). Proliferative zone significantly correlated with innate inflammatory markers TLR-4 and NF-κB (Table 2) indicating that innate inflammation has an effect on proliferative kinetics of colonic epithelial cells. Recent research has shown that NF-κB plays a role in epithelial cell proliferation by increasing nuclear β-catenin accumulation upon exposure to innate inflammation such as in colitis (35). Our strong correlation of proliferative zone to innate inflammatory markers further lends support to how a HCD diet can elevate the risk for colon cancer. Lipocalin-2 (LCN2) is a stable and non-invasive marker of intestinal inflammation, which is secreted by both immune cells (primarily neutrophils) and colonic epithelial cells (36). LCN-2 expression is induced upon activation of toll-like receptors on immune cells. HCD consuming pigs had elevated levels of LCN-2 (Supplementary table 3). Proliferative zone significantly correlated with LCN2 measured in the colonic mucosa (Table 2), thus indicating that inflammation induced stress elevates proliferation in colon epithelial cells. In addition, proliferative zone correlated positively with inflammatory marker IL-6 (Table 2). Interleukin 6 (IL-6) was shown to be a critical promoter of epithelial cell proliferation in mice models of colitis-associated cancer (37). Further, IL-6 has been shown to mediate hypoferremia (iron deficiency). However, HCD consuming pigs in our study didn’t have differences in serum iron levels compared to SD consuming pigs (Figure 1E). This can be probably explained by the low-grade chronic inflammation induced by HCD and thus allowing us to observe the effect of inflammation on colon kinetics without any systemic changes in the iron levels. The lack of stem cell zone correlations to inflammatory markers could be attributed to the asymmetric division of stem cells. Colonic stem cells divide asymmetrically to give rise to a daughter stem cell and a progenitor cell (38). Progenitor cells proliferate multiple times and differentiate into the various subtypes of colon epithelial cells, hence the strong correlation between proliferative index/zone (which accounts for all the proliferating cells) to inflammatory markers.

The colonic microbiota is estimated to comprise over 1014 bacteria from more than 1,000 different species. The results of the human microbiome project (39) by the National Institutes of Health described more than 70 bacterial phyla with four constituting the majority of mammalian microbiota (Bacteroidetes, Firmicutes, Actinobacteria, and Proteobacteria). In this study, we were able to test the relevance of these changes to host colonic epithelial cell kinetics. Stem cell zone and proliferative index positively correlated with an increase in proteobacteria phylum, which has been associated with colitis and colorectal cancer (40). E. coli, a member of Enterobacteriaceae family/Proteobacteria phylum, has been shown to produce colibactin, a genotoxin responsible for the promotion of colon cancer in chronic inflammatory mice models (40). HCD consumption is marked by a decrease in butyrate producing bacteria (like Clostridia which are part of the Firmicutes phyla) and increase in proteobacteria. Proteobacteria lineages with more genes for signal transduction, cell migration/motility and membrane transport are increased in abundance on the high-fat diet (41). Thus, the correlation of colonic epithelial cell kinetics with inflammation and proteobacteria indicates a potential role of gut bacteria in high-calorie diet elevated colon cancer risk.

Correlation ranking of proteomic pathways revealed an association with pathways that are involved in proliferation, cell junction and cytoskeleton signaling (migration/motility) and inflammation. FAK, ERK/MAPK, eIF4, and mTOR are pathways involved in increased proliferation that correlated with stem cell zone (Table 3). Mitogen-activated protein kinase (ERK/MAPK) and rapamycin-sensitive mTORC1 pathways are evolutionarily conserved kinase modules that link extracellular signals to fundamental cellular processes such as growth, proliferation, differentiation, migration and apoptosis (42). Recently, calorie alterations in animals have been shown to cause an increase in stem cell proliferation (43). eIF4 is involved in translation up-regulation in the presence of growth factors (which are elevated in HCD consuming animals) (44). Actin cytoskeleton provides a supportive framework to the three-dimensional structure of cells and enables the cell to adopt a variety of shapes and to undertake directed movements. The correlation of this pathway to proliferative zone and index provides substantial basis for migration of proliferating cells across the colon crypt. This is particularly important in chronic inflammatory conditions, as migration across the crypt column leads to elevated exposure to intestinal luminal toxins resulting in a greater chance of acquiring mutations while proliferating. Gap Junction signaling is critically important in regulating tissue homeostasis, apoptosis, metabolic transport and normal cell growth and differentiation (45). Junction dynamics are affected by cytokines like TNFα, which was elevated in our study and other chronic inflammatory conditions. Additionally, the cytokine and growth factor activated signaling pathways – STAT3 and IL-2 correlated with stem cell zone, proliferative index, and proliferative zone respectively. Collectively, this shows that the enhanced presence of growth factors and inflammation in HCD conditions can cause these alterations in gap junction signaling which leads to altered colonic epithelial cell kinetics.

Based on the data, we can conclude that pigs contains both type of colonic stems cells (ASCL-2 and BMI-1; mice colon lacks BMI-1 type stem cells) similar to human and the high-calorie diet induced changes in gut bacterial composition and elevated inflammation can result in stress to the colon epithelium leading to elevated proliferative zone and index and stem cell zone. These changes are independent of calorie intake, body weight, and serum iron levels and before the onset of glucose intolerance. This elevation is further reflected in the colon epithelial proteome – high correlation to proliferation and motility pathways. Proliferating colonocytes are highly susceptible to toxicants from sources such as gut bacteria and diet. This is particularly important as up to 85% of the colon cancer cases are attributed to diet and lifestyle factors. Given that pig has distinct colonic stem cell population and gut bacterial profile similar to humans, the pig model can be utilized in the development of preventive and therapeutic agents/strategies against gut bacterial dysbiosis and inflammation promoted diseases such as colon cancer and type 2 diabetes.

Supplementary Material

1
2

Acknowledgments

J.V. is the PI of USDA-NIFA NRI Integrated Grant 2009-55200-05197 that supported this work. We thank members of SWK laboratory at North Carolina State University for their assistance with the pig study. We appreciate the help for the pig studies provided by members of the North Carolina State University Swine Education Unit, Raleigh, NC, Swine Evaluation Unit, Clayton, NC and North Carolina State University Feed Mill, Raleigh, NC. Abigail Sido measured IL-6 expression under the supervision of JV and this data was used for correlations performed in this study. We would also like to thank Dr. Na Xiong from Pennsylvania State University for providing thoughtful feedback on the manuscript draft.

Financial support

J.K.P. Vanamala is the PI of USDA-NIFA NRI Integrated Grant 2009-55200-05197 that supported this work. Gut bacterial analysis was partially funded by HHMI Early Career Scientist award to R. Knight. Q. Li was partially supported by NIH R01GM109453 and 1UL1RR033184-01.

Footnotes

Conflict of interest – None declared

Author contribution

SR conducted pig study under the supervision of JV, SWK and LR. SR measured serum glucose and insulin levels, and inflammation markers under the supervision of JV. XX performed the serum iron analysis under the supervision of MVK. EE performed proliferative zone and index analysis under the supervision of JV. VC performed stem cell identification using immunohistochemistry and correlations under supervision of JV. LR, VC and SR performed extraction of DNA from pig feces for bacterial sequencing analysis. LR and JV worked with RK lab to obtain 16S rRNA sequencing and data analysis. SR developed the protocol for protein extraction for proteomics under the supervision of JV and VBB performed LC-MS-MS. FS, QL, SR and JV worked on proteomics data analyses. VC drafted the manuscript under the supervision of JV. JV, LR and SR provided critical input on the manuscript draft and helped in shaping the final version. All authors read and approved the final manuscript.

References

  • 1.Barker N. Adult intestinal stem cells: critical drivers of epithelial homeostasis and regeneration. Nature reviews Molecular cell biology. 2014;15:19–33. doi: 10.1038/nrm3721. [DOI] [PubMed] [Google Scholar]
  • 2.Beyaz S, Mana MD, Roper J, Kedrin D, Saadatpour A, Hong S-J, et al. High-fat diet enhances stemness and tumorigenicity of intestinal progenitors. Nature. 2016;531:53–58. doi: 10.1038/nature17173. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Reuter S, Gupta SC, Chaturvedi MM, Aggarwal BB. Oxidative stress, inflammation, and cancer: how are they linked? Free Radical Biology and Medicine. 2010;49:1603–1616. doi: 10.1016/j.freeradbiomed.2010.09.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Lonkar P, Dedon PC. Reactive species and DNA damage in chronic inflammation: reconciling chemical mechanisms and biological fates. International Journal of Cancer. 2011;128:1999–2009. doi: 10.1002/ijc.25815. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Martinez-Montiel Mdel P, Gomez-Gomez GJ, Flores AI. Therapy with stem cells in inflammatory bowel disease. World journal of gastroenterology : WJG. 2014;20:1211–1227. doi: 10.3748/wjg.v20.i5.1211. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Winzell MS, Ahrén B. The high-fat diet-fed mouse a model for studying mechanisms and treatment of impaired glucose tolerance and type 2 diabetes. Diabetes. 2004;53:S215–S219. doi: 10.2337/diabetes.53.suppl_3.s215. [DOI] [PubMed] [Google Scholar]
  • 7.Day SD, Enos RT, McClellan JL, Steiner J, Velázquez KT, Murphy E. Linking inflammation to tumorigenesis in a mouse model of high-fat-diet-enhanced colon cancer. Cytokine. 2013;64:454–462. doi: 10.1016/j.cyto.2013.04.031. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Control CfD, Prevention. National diabetes statistics report: estimates of diabetes and its burden in the United States, 2014. Atlanta, GA: US Department of Health and Human Services; 2014. [Google Scholar]
  • 9.Li H, Lelliott C, Hakansson P, Ploj K, Tuneld A, Verolin-Johansson M, et al. Intestinal, adipose, and liver inflammation in diet-induced obese mice. Metabolism: clinical and experimental. 2008;57:1704–1710. doi: 10.1016/j.metabol.2008.07.029. [DOI] [PubMed] [Google Scholar]
  • 10.Kim KA, Gu W, Lee IA, Joh EH, Kim DH. High fat diet-induced gut microbiota exacerbates inflammation and obesity in mice via the TLR4 signaling pathway. PloS one. 2012;7:e47713. doi: 10.1371/journal.pone.0047713. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Winer DA, Luck H, Tsai S, Winer S. The intestinal immune system in obesity and insulin resistance. Cell metabolism. 2016;23:413–426. doi: 10.1016/j.cmet.2016.01.003. [DOI] [PubMed] [Google Scholar]
  • 12.van der Flier LG, van Gijn ME, Hatzis P, Kujala P, Haegebarth A, Stange DE, et al. Transcription factor achaete scute-like 2 controls intestinal stem cell fate. Cell. 2009;136:903–912. doi: 10.1016/j.cell.2009.01.031. [DOI] [PubMed] [Google Scholar]
  • 13.Sangiorgi E, Capecchi MR. Bmi1 is expressed in vivo in intestinal stem cells. Nature genetics. 2008;40:915–920. doi: 10.1038/ng.165. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Barker N, van Es JH, Kuipers J, Kujala P, van den Born M, Cozijnsen M, et al. Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature. 2007;449:1003–1007. doi: 10.1038/nature06196. [DOI] [PubMed] [Google Scholar]
  • 15.Yan KS, Chia LA, Li X, Ootani A, Su J, Lee JY, et al. The intestinal stem cell markers Bmi1 and Lgr5 identify two functionally distinct populations. Proceedings of the National Academy of Sciences. 2012;109:466–471. doi: 10.1073/pnas.1118857109. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Xiao X, San Yeoh B, Saha P, Olvera RA, Singh V, Vijay-Kumar M. Lipocalin 2 alleviates iron toxicity by facilitating hypoferremia of inflammation and limiting catalytic iron generation. BioMetals. 2016;29:451–465. doi: 10.1007/s10534-016-9925-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Caporaso JG, Lauber CL, Walters WA, Berg-Lyons D, Huntley J, Fierer N, et al. Ultra-high-throughput microbial community analysis on the Illumina HiSeq and MiSeq platforms. The ISME journal. 2012;6:1621–1624. doi: 10.1038/ismej.2012.8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Edgar RC. Search and clustering orders of magnitude faster than BLAST. Bioinformatics. 2010;26:2460–2461. doi: 10.1093/bioinformatics/btq461. [DOI] [PubMed] [Google Scholar]
  • 19.DeSantis TZ, Hugenholtz P, Larsen N, Rojas M, Brodie EL, Keller K, et al. Greengenes, a chimera-checked 16S rRNA gene database and workbench compatible with ARB. Applied and environmental microbiology. 2006;72:5069–5072. doi: 10.1128/AEM.03006-05. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Newmark HL, Yang K, Kurihara N, Fan K, Augenlicht LH, Lipkin M. Western-style diet-induced colonic tumors and their modulation by calcium and vitamin D in C57Bl/6 mice: a preclinical model for human sporadic colon cancer. Carcinogenesis. 2009;30:88–92. doi: 10.1093/carcin/bgn229. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Vanamala J, Radhakrishnan S, Eriksson E, Charepalli V, Kim S, Reddivari L. High-fat diet induced expansion of colon crypt epithelial proliferative zone towards lumen correlates with elevated innate inflammatory markers in the human-relevant porcine model. The FASEB Journal. 2014;28 Supplement 123.2. [Google Scholar]
  • 22.Myant KB, Cammareri P, McGhee EJ, Ridgway RA, Huels DJ, Cordero JB, et al. ROS production and NF-kappaB activation triggered by RAC1 facilitate WNT-driven intestinal stem cell proliferation and colorectal cancer initiation. Cell Stem Cell. 2013;12:761–773. doi: 10.1016/j.stem.2013.04.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Zhang T, Otevrel T, Gao Z, Ehrlich SM, Fields JZ, Boman BM. Evidence that APC regulates survivin expression: a possible mechanism contributing to the stem cell origin of colon cancer. Cancer Res. 2001;61:8664–8667. [PubMed] [Google Scholar]
  • 24.Ley RE, Bäckhed F, Turnbaugh P, Lozupone CA, Knight RD, Gordon JI. Obesity alters gut microbial ecology. Proceedings of the National Academy of Sciences of the United States of America. 2005;102:11070–11075. doi: 10.1073/pnas.0504978102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Mujico JR, Baccan GC, Gheorghe A, Díaz LE, Marcos A. Changes in gut microbiota due to supplemented fatty acids in diet-induced obese mice. British Journal of Nutrition. 2013;110:711–720. doi: 10.1017/S0007114512005612. [DOI] [PubMed] [Google Scholar]
  • 26.Harris TE, Thorner MO. Caloric Restriction in mTORC1 Control of Intestinal Homeostasis. Cell metabolism. 2012;16:6–8. doi: 10.1016/j.cmet.2012.06.010. [DOI] [PubMed] [Google Scholar]
  • 27.Cima I, Corazza N, Dick B, Fuhrer A, Herren S, Jakob S, et al. Intestinal epithelial cells synthesize glucocorticoids and regulate T cell activation. The Journal of experimental medicine. 2004;200:1635–1646. doi: 10.1084/jem.20031958. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Bostick RM, Fosdick L, Grandits GA, Lillemoe T, Wood J, Grambsch P, et al. Colorectal epithelial cell proliferative kinetics and risk factors for colon cancer in sporadic adenoma patients. Cancer Epidemiology Biomarkers & Prevention. 1997;6:1011–1019. [PubMed] [Google Scholar]
  • 29.Jensen BA, Nielsen TS, Fritzen AM, Holm JB, Fjære E, Serup AK, et al. Dietary fat drives whole-body insulin resistance and promotes intestinal inflammation independent of body weight gain. Metabolism: clinical and experimental. 2016;65:1706–1719. doi: 10.1016/j.metabol.2016.09.002. [DOI] [PubMed] [Google Scholar]
  • 30.Tian H, Biehs B, Warming S, Leong KG, Rangell L, Klein OD, et al. A reserve stem cell population in small intestine renders Lgr5-positive cells dispensable. Nature. 2011;478:255–259. doi: 10.1038/nature10408. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Kim JH, Yoon SY, Kim C-N, Joo JH, Moon SK, Choe IS, et al. The Bmi-1 oncoprotein is overexpressed in human colorectal cancer and correlates with the reduced p16INK4a/p14ARF proteins. Cancer letters. 2004;203:217–224. doi: 10.1016/j.canlet.2003.07.009. [DOI] [PubMed] [Google Scholar]
  • 32.Takeda K, Akira S. TLR signaling pathways. Semin Immunol. 2004;16:3–9. doi: 10.1016/j.smim.2003.10.003. [DOI] [PubMed] [Google Scholar]
  • 33.Chait A, Kim F. Saturated fatty acids and inflammation: who pays the toll? Arterioscler Thromb Vasc Biol. 2010;30:692–693. doi: 10.1161/ATVBAHA.110.203984. [DOI] [PubMed] [Google Scholar]
  • 34.Maury E, Brichard SM. Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome. Mol Cell Endocrinol. 2010;314:1–16. doi: 10.1016/j.mce.2009.07.031. [DOI] [PubMed] [Google Scholar]
  • 35.Salcedo R, Worschech A, Cardone M, Jones Y, Gyulai Z, Dai R-M, et al. MyD88-mediated signaling prevents development of adenocarcinomas of the colon: role of interleukin 18. The Journal of experimental medicine. 2010;207:1625–1636. doi: 10.1084/jem.20100199. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Chassaing B, Srinivasan G, Delgado MA, Young AN, Gewirtz AT, Vijay-Kumar M. Fecal lipocalin 2, a sensitive and broadly dynamic non-invasive biomarker for intestinal inflammation. PloS one. 2012;7:e44328. doi: 10.1371/journal.pone.0044328. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Hu B, Elinav E, Huber S, Strowig T, Hao L, Hafemann A, et al. Microbiota-induced activation of epithelial IL-6 signaling links inflammasome-driven inflammation with transmissible cancer. Proceedings of the National Academy of Sciences of the United States of America. 2013;110:9862–9867. doi: 10.1073/pnas.1307575110. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Potten CS, Owen G, Booth D. Intestinal stem cells protect their genome by selective segregation of template DNA strands. J Cell Sci. 2002;115:2381–2388. doi: 10.1242/jcs.115.11.2381. [DOI] [PubMed] [Google Scholar]
  • 39.Peterson J, Garges S, Giovanni M, McInnes P, Wang L, Schloss JA, et al. The NIH human microbiome project. Genome research. 2009;19:2317–2323. doi: 10.1101/gr.096651.109. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Arthur JC, Perez-Chanona E, Mühlbauer M, Tomkovich S, Uronis JM, Fan T-J, et al. Intestinal inflammation targets cancer-inducing activity of the microbiota. science. 2012;338:120–123. doi: 10.1126/science.1224820. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Hildebrandt MA, Hoffmann C, Sherrill-Mix SA, Keilbaugh SA, Hamady M, Chen YY, et al. High-fat diet determines the composition of the murine gut microbiome independently of obesity. Gastroenterology. 2009;137:1716–1724. e2. doi: 10.1053/j.gastro.2009.08.042. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Kim EK, Choi E-J. Pathological roles of MAPK signaling pathways in human diseases. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease. 2010;1802:396–405. doi: 10.1016/j.bbadis.2009.12.009. [DOI] [PubMed] [Google Scholar]
  • 43.Laplante M, Sabatini DM. mTOR signaling in growth control and disease. Cell. 2012;149:274–293. doi: 10.1016/j.cell.2012.03.017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Magnuson B, Ekim B, Fingar DC. Regulation and function of ribosomal protein S6 kinase (S6K) within mTOR signalling networks. Biochemical Journal. 2012;441:1–21. doi: 10.1042/BJ20110892. [DOI] [PubMed] [Google Scholar]
  • 45.Nicholson BJ. Gap junctions-from cell to molecule. Journal of cell science. 2003;116:4479–4481. doi: 10.1242/jcs.00821. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

1
2

RESOURCES